Related Experiment Video
Updated: Aug 20, 2026

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder
Lucy K Martin1, Paolo Romanelli, Yeon Soong Ahn
1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, University of Miami, Miami, FL 33125, USA.
International Journal of Dermatology
|December 1, 2004
Abstract:
Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.